Support for Export Companies' Licensing and Regulatory Consultation

The Korea Pharmaceutical and Bio-Pharma Manufacturers Association and the Ministry of Food and Drug Safety officially launched the "Pharmaceutical Export Regulation Support Office" on January 30 to provide support for pharmaceutical export regulations and offer regulatory information and consultation services for exporting companies.


Opening Ceremony of the Pharmaceutical Export Regulation Support Office. Korea Pharmaceutical and Bio-Pharma Manufacturers Association

Opening Ceremony of the Pharmaceutical Export Regulation Support Office. Korea Pharmaceutical and Bio-Pharma Manufacturers Association

View original image

The office was newly established to address the challenges faced by domestic companies due to complex licensing systems and regulatory barriers in each country, through public-private cooperation. It supports companies by analyzing and providing overseas licensing cases and regulatory systems, offering regulatory consultation, and creating opportunities for communication with regulatory authorities in export destinations, thereby helping companies obtain licenses for pharmaceutical exports more easily.


Over the past two years, the association has identified and submitted more than 200 cases of export regulatory challenges. In particular, it has built up expertise in regulatory support by dispatching joint public-private delegations to major export countries such as Vietnam, Indonesia, and Japan, identifying bilateral consultation agendas with local regulatory agencies, and holding licensing system seminars and business meetings.


Through the operation of the Export Licensing Support Office, the association will continuously monitor companies' difficulties related to export and licensing. In addition, institutional issues that are difficult for individual companies to resolve will be elevated to the level of cooperation agendas between regulatory authorities to seek solutions.


Oh Yu-kyoung, Commissioner of the Ministry of Food and Drug Safety, stated, "The office will serve as a problem solver on the ground, addressing companies' challenges and acting as a professional guide by providing licensing cases and regulatory information. It will become a strong support for exporting companies. The Ministry of Food and Drug Safety will not remain just a 'regulatory authority,' but will continue to expand regulatory services to support companies' global achievements."



Noh Yeonhong, President of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, said, "We will provide frontline support to overcome the greatest challenge companies face in the export process?overseas licensing regulatory barriers. Together with the Ministry of Food and Drug Safety, we will strive to ensure that the office serves as a priming water for pharmaceutical exports."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing